Showing results (2251-2260 of 39,505) with videos related to

Sort By:
Pageof 3,951
Blood|October 11, 2003
Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trialJeanet M Kemmeren, Ale Algra, Joost C M Meijers, et al.
Blood|October 11, 2003
Prior chemotherapy and allograft CD34+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with solid tumorsCristian Carvallo, Nancy Geller, Roger Kurlander, et al.
Blood|June 1, 1992
Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancerA D Elias, L Ayash, K C Anderson, et al.
Blood|November 1, 1976
Mechanisms involved in enhancement of plasma fibrinolytic activity by chloroformL A Moroz, N J Gilmore
Blood|November 15, 1992
Antilymphocytic antibodies and marrow transplantation. XII. Suppression of graft-versus-host disease by T-cell-modulating and depleting antimouse CD3 antibody is most effective when preinjected in the marrow recipientJ Mysliwietz, S Thierfelder
Blood|December 15, 1992
Influenza A virus binding to human neutrophils and cross-linking requirements for activationD E Daigneault, K L Hartshorn, L S Liou, et al.
Blood|December 1, 1992
15-Hydroxyeicosatetraenoic acid-mediated potentiation of thrombin-induced platelet functions occurs via enhanced production of phosphoinositide-derived second messengers--sn-1,2-diacylglycerol and inositol-1,4,5-trisphosphateB N Setty, M H Werner, Y A Hannun, et al.
Blood|December 1, 1992
Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphateM Cattaneo, A Lecchi, A M Randi, et al.
Blood|November 15, 1992
Circulating cytomegalovirus (CMV) neutralizing activity in bone marrow transplant recipients: comparison of passive immunity in a randomized study of four intravenous IgG products administered to CMV-seronegative patientsA H Filipovich, M H Peltier, M K Bechtel, et al.
Blood|March 15, 1992
Protein CVermont: symptomatic type II protein C deficiency associated with two GLA domain mutationsE G Bovill, J A Tomczak, B Grant, et al.
Pageof 3,951